Literature DB >> 24785410

Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.

Teresa Oloriz1, John Silberbauer1, Giuseppe Maccabelli1, Hiroya Mizuno1, Francesca Baratto1, Senthil Kirubakaran1, Pasquale Vergara1, Caterina Bisceglia1, Giulia Santagostino1, Alessandra Marzi1, Nicoleta Sora1, Carla Roque1, Fabrizio Guarracini1, Dimitris Tsiachris1, Andrea Radinovic1, Manuela Cireddu1, Simone Sala1, Simone Gulletta1, Gabriele Paglino1, Patrizio Mazzone1, Nicola Trevisi1, Paolo Della Bella2.   

Abstract

BACKGROUND: The aim was to relate distinct scar distributions found in nonischemic cardiomyopathy with ventricular tachycardia (VT) morphology, late potential distribution, ablation strategy, and outcome. METHODS AND
RESULTS: Eighty-seven patients underwent catheter ablation for drug-refractory VT. Based on endocardial unipolar voltage, 44 were classified as predominantly anteroseptal and 43 as inferolateral. Anteroseptal patients more frequently fulfilled diagnostic criteria for dilated cardiomyopathy (64% versus 36%), associated with more extensive endocardial unipolar scar (41 [22-83] versus 9 [1-29] cm(2); P<0.001). Left inferior VT axis was predictive of anteroseptal scar (positive predictive value, 100%) and right superior axis for inferolateral (positive predictive value, 89%). Late potentials were infrequent in the anteroseptal group (11% versus 74%; P<0.001). Epicardial late potentials were common in the inferolateral group (81% versus 4%; P<0.001) and correlated with VT termination sites (κ=0.667; P=0.014), whereas no anteroseptal patient had an epicardial VT termination (P<0.001). VT recurred in 44 patients (51%) during a median follow-up of 1.5 years. Anteroseptal scar was associated with higher VT recurrence (74% versus 25%; log-rank P<0.001) and redo procedure rates (59% versus 7%; log-rank P<0.001). After multivariable analysis, clinical predictors of VT recurrence were electrical storm (hazard ratio, 3.211; P=0.001) and New York Heart Association class (hazard ratio, 1.608; P=0.018); the only procedural predictor of VT recurrence was anteroseptal scar pattern (hazard ratio, 5.547; P<0.001).
CONCLUSIONS: Unipolar low-voltage distribution in nonischemic cardiomyopathy allows categorization of scar pattern as inferolateral, often requiring epicardial ablation mainly based on late potentials, and anteroseptal, which frequently involves an intramural septal substrate, leading to a higher VT recurrence.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathies; tachycardia, ventricular

Mesh:

Year:  2014        PMID: 24785410     DOI: 10.1161/CIRCEP.114.001568

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  29 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 2.  [Epicardial VT ablation : In whom, when, how and why?]

Authors:  E Ene; P Halbfaß; K Nentwich; K Sonne; A Berkovitz; A-K Wolf; T Deneke
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-06-26

Review 3.  Interventional Pericardiology.

Authors:  Mandeep Bhargava; Oussama M Wazni; Walid I Saliba
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 5.  [Epicardial ablation of ventricular tachycardias].

Authors:  E Ene; P Halbfaß; K Nentwich; K Sonne; M Roos; S Fodor; L Lehmkuhl; F Gietzen; S Barth; K Hamm; T Deneke
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-09

6.  Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.

Authors:  Tomas Vita; Christoph Gräni; Siddique A Abbasi; Tomas G Neilan; Ethan Rowin; Kyoichi Kaneko; Otavio Coelho-Filho; Eri Watanabe; Francois-Pierre Mongeon; Hoshang Farhad; Carlos Henrique Rassi; Yuna L Choi; Kathleen Cheng; Michael M Givertz; Ron Blankstein; Michael Steigner; Ayaz Aghayev; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2018-11-15

7.  Successful Ablation of Single Reentrant Ventricular Tachycardia Arising from Peri-Aortic Scar in a Patient with an Apparently Normal Heart.

Authors:  Hiro Yamasaki; Gerhard Hindricks; Arash Arya; Philipp Sommer
Journal:  J Atr Fibrillation       Date:  2015-02-28

8.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

9.  Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease.

Authors:  Jackson J Liang; Pasquale Santangeli; David J Callans
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

10.  Ventricular Tachycardia Ablation - The Right Approach for the Right Patient.

Authors:  Mouhannad M Sadek; Robert D Schaller; Gregory E Supple; David S Frankel; Michael P Riley; Mathew D Hutchinson; Fermin C Garcia; David Lin; Sanjay Dixit; Erica S Zado; David J Callans; Francis E Marchlinski
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.